A5019747180- Liver Disease and Transplantation
- Organ Transplantation Techniques and Outcomes
- Pancreatic and Hepatic Oncology Research
- Pancreatitis Pathology and Treatment
- Liver Disease Diagnosis and Treatment
- Renal cell carcinoma treatment
- Renal Transplantation Outcomes and Treatments
- Respiratory Support and Mechanisms
- Hepatitis B Virus Studies
- Hepatocellular Carcinoma Treatment and Prognosis
- Neuroendocrine Tumor Research Advances
- Gallbladder and Bile Duct Disorders
- Inflammatory Biomarkers in Disease Prognosis
- Hepatitis C virus research
- Esophageal and GI Pathology
- Colorectal Cancer Surgical Treatments
- Nutrition and Health in Aging
- Organ Donation and Transplantation
Northwell Health
2024
Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2024
Emory University Hospital
2024
Kyoto University
2019-2022
Alexandria University
2018-2021
Menoufia University
2019-2020
Screening Program to Eliminate Hepatitis C in Egypt In 2018, the Egyptian government initiated a massive hepatitis screening and treatment program. The Ministry of Health set goal screenin...
Adult‐to‐adult living donor liver transplantation (ALDLT) using small‐for‐size grafts (SFSGs), ie, a graft with graft‐to‐recipient weight ratio (GRWR) <0.8%, has been challenge that should be carefully dealt with, and risk factors in this category are unclear. Therefore, we aimed to examine the outcomes of ALDLT SFSGs over 13‐year period 121 patients who had undergone their first SFSGs. Small‐for‐size syndrome (SFSS), early loss, 1‐year mortality were encountered 21.6%, 14.9%, 18.4%...
The aim in the present study was to elucidate diagnostic ability of presepsin for postoperative infectious complications following major hepato-biliary-pancreatic (HBP) surgery.Between 2017 and 2019, 50 patients with hepatectomy 55 pancreatoduodenectomy were enrolled. Presepsin, neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), procalcitonin (PCT) prospectively measured first 2 weeks after surgery. abilities these biomarkers compared multidirectionally.All returned normal...
Abernethy syndrome is a rare congenital anomaly characterized by an intrahepatic or extrahepatic portosystemic shunt. Most patients are asymptomatic; however, due to the alteration in, lack of, portovenous flow, with at high risk of developing sequelae liver failure. Once these complications develop, only definitive treatment transplantation. Patients also higher benign and malignant lesions, including hepatic adenomas. Here, we describe first case deceased donor transplantation as for...